Subramanian VS, Srinivasan P, Said HM. Uptake of ascorbic acid by pancreatic acinar cells is negatively impacted by chronic alcohol exposure. Am J Physiol Cell Physiol 311: C129 -C135, 2016. First published April 27, 2016; doi:10.1152/ajpcell.00042.2016.-Vitamin C (ascorbic acid, AA) is indispensable for normal metabolism of all mammalian cells including pancreatic acinar cells (PACs). PACs obtain AA from their surroundings via transport across the cell membrane. Chronic alcohol exposure negatively affects body AA homeostasis; it also inhibits uptake of other micronutrients into PACs, but its effect on AA uptake is not clear. We examined this issue using both in vitro (266-6 cells) and in vivo (mice) models of chronic alcohol exposure. First, we determined the relative expression of the AA transporters 1 and 2 [i.e., sodium-dependent vitamin C transporter-1 (SVCT-1) and SVCT-2] in mouse and human PACs and found SVCT-2 to be the predominant transporter. Chronic exposure of 266-6 cells to alcohol significantly inhibited AA uptake and caused a marked reduction in SVCT-2 expression at the protein, mRNA, and heterogeneous nuclear RNA (hnRNA) levels. Similarly, chronic alcohol feeding of mice significantly inhibited AA uptake and caused a marked reduction in level of expression of the SVCT-2 protein, mRNA, and hnRNA. These findings suggest possible involvement of transcriptional mechanism(s) in mediating chronic alcohol effect on AA uptake by PACs. We also observed significant epigenetic changes (histone modifications) in the Slc23a2 gene (reduction in H3K4me3 level and an increase in H3K27me3 level) in the alcohol-exposed 266-6 cells. These findings show that chronic alcohol exposure inhibits PAC AA uptake and that the effect is mediated, in part, at the level of transcription of the Slc23a2 gene and may involve epigenetic mechanism(s).
ASCORBIC ACID (AA), a member of the water-soluble family of vitamins, is essential for normal metabolism and function of all mammalian cells because of its role as a cofactor for several important enzymes and as an antioxidant (29) . Systemic deficiency of the vitamin leads to a variety of clinical abnormalities that include scurvy, delayed wound healing, bone and connective tissue damage, and vasomotor instability (29) . Optimization of body levels of vitamin C, on the other hand, has been reported to protect against gallbladder diseases, osteoporosis, cardiovascular disease, cancer, and cataract formation (7, 8, 33, 37) . At the cellular level, deficiency of AA leads to an increase in oxidative stress (5) . Therefore, studies that aim at improving our knowledge and understanding of the cellular and molecular mechanisms involved in maintaining and regulating vitamin C body and cellular homeostasis are of clear importance.
Human cells (including pancreatic acinar cells, PACs) cannot synthesize AA; rather they obtain the vitamin from their surroundings. Mice can synthesize AA endogenously, but their PACs still rely on the vitamin that exists in the circulation to meet their needs of this micronutrient, as shown by studies utilizing knockout mouse models (9, 38) . In mammals (including human and mouse), two membrane transport systems have been identified for cellular uptake of AA, the sodium-dependent vitamin C transporter-1 and -2 (SVCT-1 and SVCT-2, products of the SLC23A1 and SLC23A2 genes, respectively) (7, 13, 31, 38, 47, 48) . These membrane carriers transport L-ascorbic acid but not its oxidized form, i.e., dehydroascorbic acid. Also significant similarity exists between the human SVCT-1 and -2 and their mouse counterparts (36) . The two AA transporters, however, show differential tissue distribution, with expression of SVCT-1 being confined to epithelia involved in bulk transport of the vitamin (like the intestine and the kidney), whereas expression of SVCT-2 is mainly in nonepithelial cell types (7) .
Chronic alcohol use in humans is associated with lower plasma AA level (15, 17, 35) . However, vitamin C appears to protect cells against alcohol-induced oxidative damage (27, 28) . We have been interested in the effect of chronic alcohol exposure on the uptake of essential micronutrients by PACs (39, 40, 45) , and in this study we examined its effect on physiological and molecular parameters of AA uptake. We utilized both an in vitro and an in vivo model of chronic alcohol exposure in our investigations. Our results showed that chronic exposure of PACs to alcohol leads to a significant inhibition in pancreatic acinar AA uptake. This inhibition is associated with a marked reduction in expression of the predominant AA transporter SVCT-2 in PACs at the protein, mRNA, and heterogeneous nuclear RNA (hnRNA) levels; it is also associated with a significant reduction in the level of the H3K4me3 (euchromatin) and an increase in the level of the H3K27me3 (heterochromatin) markers in the Slc23a2 predicted promoter region. These findings demonstrate that chronic alcohol exposure impairs AA uptake by PAC and that the effect is (in part) mediated via transcriptional mechanism(s) of the Slc23a2 gene and may involve epigenetic alterations. (43) . Anti-SVCT-2 and anti-GAPDH polyclonal primary antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-rabbit IRDye-800 and anti-rabbit IRDye-680 secondary antibodies were purchased from LI-COR Bioscience (Lincoln, NE). Oligonucleotide primers used in this study were synthesized by Sigma Genosys (Sigma, Woodland, TX).
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MATERIALS AND METHODS
Materials
Cell culture, alcohol exposure, and uptake studies. The 266-6 cells were cultured in DMEM growth medium containing 10% fetal bovine serum and penicillin/streptomycin. Cells were used between passages 3-20. Ethanol (50 mM) [a concentration similar to the blood alcohol level of chronic alcoholics (14) ] containing DMEM medium was added to the 266-6 cells, and cells were grown in an ethanol-saturated 5% CO 2 incubator maintained at 37°C for 96 h with media change every 12 h to minimize change in ethanol concentration in medium (30, 45) . Uptake (3 min, initial rate) was measured at 37°C in cells suspended in Krebs-Ringer (K-R) buffer [containing (in mM) 133.00 NaCl, 4.93 KCl, 1.23 MgSO 4, 0.85 CaCl2, 5.00 glucose, 5.00 glutamine, 10.00 HEPES, and 10.00 MES; pH 7.4], and the reaction was terminated by the addition of ice-cold K-R buffer, then digested and neutralized with 1 N NaOH and 10 N HCl, respectively. The radioactive content was measured using a scintillation counter (Beckman Coulter LS 6500 multipurpose counter; Miami, Florida). The protein content was determined using a protein assay kit (Bio-Rad, Hercules, CA).
Ethanol feeding of mice and isolation of mouse primary PACs. The mice were fed the Lieber-DeCarli ethanol liquid diet (Dyets, Bethlehem, PA) [ethanol provided 25% of total ingested calories (25) ] for 4 wk as described before (45) . Control mice were pair fed with the same liquid diet but without ethanol (maltose-dextrin isocalorically replaced ethanol). PACs were isolated from the pancreas of chronically alcohol-fed and their pair-fed control mice using a collagenase-type IV (Lakewood, NJ) digestion method as described before (39, 42, 45) . Isolated PAC viability was tested by Trypan blue exclusion method, and this preparation was shown to be greater than 90% viability. These cells were processed for 14 C-AA uptake and for protein, RNA, and hnRNA expression studies. The use of mice in this study was approved by the Institutional Animal Care Use Committee (IACUC) of the Long Beach VA Medical Center.
RT-qPCR analysis. One microgram of total RNA was treated with DNase I (Invitrogen, Carlsbad, CA) followed by cDNA synthesis using iScript cDNA synthesis kit (Bio-Rad). To amplify the coding region of mSVCT-1, mSVCT-2, hSVCT-1, hSVCT-2, h␤-actin, and acidic ribosomal phosphoprotein, we used the gene-specific primers (Table 1) . RT-qPCR conditions and quantification were performed as described before (26, 42, 45) .
Western blot analysis. Cell lysates were isolated from chronically alcohol-exposed 266-6 cells and control cells as well as from mice chronically fed alcohol and their pair-fed control primary PACs. The protein (60 g) samples were electrophoretically separated in Nu-PAGE 4 -12% Bis-Tris gradient minigels (Invitrogen), then transferred onto Immobilon polyvinylidene difluoride membrane (Fisher Scientific). The anti-SVCT-2 and GAPDH (1:200 dilutions) antibodies were used as primary antibodies. The anti-rabbit IRDye-800 and anti-rabbit IRDye-680 (both at 1:30,000 dilutions) were sequentially used as secondary antibodies. The immunoreactive bands were detected, and their densities were quantified using the Odyssey infrared imaging system and associated software, respectively (LI-COR Bioscience).
hnRNA analysis. One microgram of RNA was isolated from the PACs (chronic alcohol-exposed 266-6 cells and their control cells; chronic alcohol-fed and their pair-fed control mice PACs) and treated with DNase I (Invitrogen). The treated RNA was then reverse transcribed and amplified by PCR using gene-specific hnRNA primers (Table 1) (1, 16, 19) .
Chromatin immunoprecipitation assay and qPCR. Chromatin immunoprecipitation (ChIP) analysis was done using the Simple ChIP enzymatic chromatin IP kit (Cell Signaling Technology, Danvers, MA). Briefly, chronic alcohol-exposed (50 mM, 96 h) and control 266-6 cells (4 ϫ 10 6 cells) were used for ChIP assay. Chromatin was cross linked with 1% formaldehyde (final concentration), and the reaction was terminated by adding glycine stop solution. Two milliliters of ice-cold PBS containing protease inhibitor cocktail (PIC) was added to the cells, which were then scraped and centrifuged at 1,500 revolution/min for 5 min and resuspended in 1 ml ice-cold buffer A containing DTT and PIC. Then the nuclei were prepared, and the chromatin was digested with micrococcal nuclease; the samples were sonicated to shear DNA into fragments followed by centrifugation at 10,000 revolution/min for 10 min, following which the chromatin was analyzed for proper digestion and concentration. Five micrograms of the digested chromatin was incubated overnight with 2 g of the specific antibody [H3, H3K4me3, H3K27me3 and IgG (Millipore, Billerica, MA)]. Finally, the immunoprecipitated samples were subjected to DNA purification and analyzed by qPCR using Slc23a2 promoter-specific primers (Table 1) to amplify the region Ϫ202 to Ϫ88 relative to transcriptional start site (TSS) (relative to TSS as ϩ1) using the PCR conditions as described before (44) . Bisulfite sequencing analysis. Bisulfite sequencing was performed to determine the methylation status of the mouse Slc23a2 promoter as described before (24, 39, 42) . DNA was isolated using Wizard Genomic DNA Purification Kit (Promega, Madison, WI) from 266-6 cells exposed to alcohol and control conditions. Bisulfite reactions were performed by following the manufacturer protocol using EpiTect Bisulfite Kit (Qiagen, Valencia, CA), and the bisulfite-treated DNA was amplified by PCR using Slc23a2 bisulfite primers (Table 1) , which span the Ϫ163 to ϩ31 (relative to TSS as ϩ1) region of CpG islands in the Slc23a2 promoter. The CpG islands were identified, and Slc23a2 bisulfite primers were designed using Methprimer (23) . The PCR was performed as described before (39) , and the resulting amplified products were ligated into pGEM-T easy vector (Promega). A minimum of 8 -10 clones from alcohol-exposed and control samples was sequenced to determine the methylation status of Slc23a2 promoter by commercial vendor (Laragen, Los Angeles, CA). After DNA sequencing, the sequence was analyzed using QUMA methylation analysis tool as described previously (21, 39) .
Data presentation and statistical analysis. 14 C-AA uptake data represent the result of at least three separate experiments and are expressed as means Ϯ SE in fmol/mg protein per 3 min. Western blot, PCR, histone modification, and DNA methylation studies were performed on at least three or more separate occasions. Data were analyzed by the Student's t-test with statistical significance set at P Ͻ 0.05.
RESULTS
Relative expression of SVCT-1 and -2 in mice and human pancreas. The relative expression of vitamin C transporters in PACs is not known and thus was determined in native mouse and human total pancreas as well as in isolated purified primary human PACs. Levels of expression of SVCT-1 and -2 mRNA were determined by RT-qPCR using total RNA. The results showed that both SVCT-1 and -2 are expressed in mouse and human pancreas as well as in human primary PACs, with expression of SVCT-2 being significantly higher than that of SVCT-1 (P Ͻ 0.01 for mouse pancreas; P Ͻ 0.02 for human pancreas; P Ͻ 0.01 for human primary PACs) (Fig. 1, A and B, i and ii, respectively).
We also determined the relative expression of SVCT-1 and -2 mRNA in 266-6 cells, our in vitro model in these investigations. The results again showed that both transporters are expressed in these cells with expression of SVCT-2 being significantly (P Ͻ 0.01) higher than that of SVCT-1 ( Fig. 2A ). We further determined the level of expression of SVCT-1 and -2 hnRNA [hnRNA is the first product of gene transcription (1, 16, 19) ] in 266-6 cells, with the results showing a significantly (P Ͻ 0.01) higher level of SVCT-2 hnRNA expression compared with SVCT-1 hnRNA in these cells (Fig. 2B) .
Collectively, the above findings clearly show that the SVCT-2 system is the predominant vitamin C transporter expressed in mouse and human PACs, and thus we focused on this transporter in our subsequent investigations.
Effect of in vitro and in vivo exposure of PACs to alcohol on physiological and molecular parameters of AA uptake process.
We investigated the effect of chronic exposure of the 266-6 cells to alcohol [50 mM, 96 h (14, 30, 45)] on carrier-mediated 14 C-AA (32 M) uptake. As mentioned earlier, although the mouse synthesize AA endogenously, PACs require extracellular AA, as shown in studies utilizing knockout mouse models for both vitamin C transporters (9, 38) . Our results showed a significant (P Ͻ 0.01) inhibition in AA uptake by chronic alcohol-exposed cells compared with controls (Fig. 3) . This inhibition was associated with a significant decrease in SVCT-2 protein (P Ͻ 0.02) (Fig. 4A ) and mRNA (P Ͻ 0.01) (Fig. 4B ) expression compared with controls.
To confirm the above-mentioned findings on the effect of the in vitro model of chronic exposure of PACs to alcohol on molecular parameters of AA uptake process in an in vivo model, we investigated the effect of chronic alcohol feeding of mice on carrier-mediated 14 C-AA (32 M) uptake and molecular parameters of the predominant transporter (SVCT-2) by primary PACs. In these studies, mice were fed an ethanolliquid diet, while their control mice were pair fed the same diet but without alcohol (see MATERIALS AND METHODS). Our results show a significant (P Ͻ 0.02) inhibition in AA uptake in alcohol-fed mice compared with their pair-fed controls (Fig. 5) . This inhibition was associated with a marked decrease in expression of SVCT-2 protein (P Ͻ 0.05) (Fig. 6A ) and mRNA (P Ͻ 0.01) (Fig. 6B ) in alcohol-fed mice compared with pair-fed controls.
Molecular mechanism(s) involved in the inhibitory effect of chronic alcohol exposure on PAC AA uptake process. The chronic exposure of 266-6 cells and mice to alcohol showed a significant inhibition in AA uptake, and this inhibition is associated with changes in SVCT-2 mRNA, which suggests possible involvement of transcriptional mechanism(s) affecting the Slc23a2 gene. To address this possibility, we examined the effect of chronic exposure of 266-6 cells to alcohol and of chronic alcohol feeding of mice on PAC level of expression of SVCT-2 hnRNA and obtained results showing a significant (P Ͻ 0.05 and P Ͻ 0.01, respectively) reduction in hnRNA expression compared with controls (Fig. 7, A and B) . These findings support the suggestion that the effect of chronic alcohol exposure/feeding on AA uptake by PACs is in part mediated via transcriptional mechanism(s) affecting the Slc23a2 gene.
Chronic alcohol exposure affects transcriptional activity of a given gene via different mechanisms, including direct effect on activity of the involved promoter, e.g., inhibition in the level of expression of a transcription factor needed for driving the activity of the promoter and/or via epigenetic modifications (2, 4, 10, 11, 34, 39, 41) . Previous studies have shown that KLF-4 and Sp-1 nuclear factors are important for transcriptional activity of the human SLC23A2 promoter (31); in addition, these cis-regulatory elements appear to be conserved in the predicted mouse Slc23a2 promoter (muscle and Mafft; mouse Slc23a2 promoter shares ϳ75% homology to the human SLC23A2 promoter). Because we have shown previously that the levels of both of these nuclear factors (KLF-4 and Sp-1) are suppressed by chronic alcohol exposure (and thus may contribute to the observed inhibition in Slc23a2 transcription), we focused our effort here on examining whether epigenetic mechanisms (i.e., histone modifications and DNA methylation) are also involved in mediating the chronic alcohol effect on Slc23a2 transcription. Histone modifications were assessed by determining possible changes in H3K4me3 (an activation mark) and H3K27me3 (a repressive mark) in 266-6 cells chronically exposed to alcohol using ChIP-qPCR of the Slc23a2 promoter. The results showed a significant (P Ͻ 0.05) reduction in the level of H3K4me3 and a significant (P Ͻ 0.05) increase in the level of H3K27me3 in cells exposed to alcohol chronically compared with control cells (Fig. 8, A and B) . Changes in methylation status of the Slc23a2 gene as a result of chronic alcohol exposure were also investigated using the Methprimer program (22) to identify CpG islands in the Slc23a2 promoter (Ϫ163 to ϩ31 relative to TSS) followed by bisulfite sequencing (see MATERIALS AND METHODS). The results, however, showed no significant changes in DNA methylation at the CpG islands of the specified Slc23a2 promoter region as a consequence of chronic alcohol exposure.
DISCUSSION
The pancreas contains high levels of vitamin C (6, 18) , where the vitamin assumes a variety of metabolic roles relevant to its normal cellular function and health. Little, however, is known about the factors (e.g., chronic alcohol exposure) that affect vitamin C uptake by PACs and about the mechanisms involved. We have begun to address these issues, and in this study we examined the effect of chronic alcohol exposure on PAC uptake of the reduced form of vitamin C, i.e., AA. We employed in vitro and in vivo chronic exposure approaches of PACs to alcohol in our investigations. First, we established the relative expression of the two known mammalian vitamin C transporters, i.e., SVCT-1 and -2 in mice and human pancreas and showed that both SVCT-1 and -2 are expressed in this tissue, with expression of the latter being significantly higher than that of the former in both species. The latter finding suggests that the SVCT-2 system assumes a more important role in AA uptake by these cells, and thus we focused on this transporter in our subsequent investigations.
Results of our investigations using the in vitro and in vivo models of chronic alcohol exposure showed a significant inhibition in carrier-mediated AA uptake by PACs exposed to alcohol compared with controls. This inhibition was associated with a significant reduction in the level of expression of the predominant SVCT-2 at the protein, mRNA, and hnRNA levels. These findings suggest that chronic alcohol exposure of PACs leads to inhibition in AA uptake and that the effect is exerted (at least in part) at the level of transcription of the Slc23a2 gene.
It is well known that a given factor can affect transcriptional activity of a particular gene via a variety of mechanisms, including an effect on the level of expression of an important nuclear factor needed to drive expression of that gene and/or via epigenetic modifications (2, 4, 11, 39, 41) . Previous studies have shown that the nuclear factors KLF-4 and Sp-1 play important roles in driving the activity of the human SLC23A2 promoter (32) (cis-elements of these nuclear factors are conserved in mouse Slc23a2 promoter). We have also shown previously that chronic alcohol exposure leads to a decrease in the expression of these factors in PACs (39, 41) . Thus it was not unreasonable to expect that part of the chronic alcohol inhibitory effect on SLC23A2 transcription in PACs was mediated via this mechanism. Whether other mechanisms, especially epigenetic modifications like histone modifications and DNA methylation (which mediate the effect of chronic alcohol exposure on expression of other genes; 2, 3, 4, 11, 12) are also involved in mediating the chronic alcohol exposure effect on the Slc23a2 transcription is not known and thus were also tested. Our findings showed that chronic exposure of 266-6 cells to alcohol is associated with a significant reduction in the level of expression of H3K4me3 (an activation mark) and a significant increase in the level of the H3K27me3 (a repressive mark) of the Slc23a2. No change, however, was seen in the methylation status of the Slc23a2 gene as a consequence of chronic alcohol exposure. These findings suggest that chronic alcohol exposure of PAC cells affects Slc23a2 transcription via mechanisms that include inhibition in the level of expression of relevant nuclear factors as well as via epigenetic modifications.
The observed inhibitory effect of chronic alcohol exposure on vitamin C transport by PACs is in contrast to its stimulatory effect on other transport genes (20, 22, 49) . It is, however, similar to its inhibitory effects on uptake of other micronutrients (39, 41) . These findings clearly show that alcohol exerts differential effects of alcohol on cellular physiological events. In summary, our results show that chronic alcohol exposure/feeding inhibits AA uptake by PACs and that the effect is, at least in part, mediated via transcriptional mechanism(s) of the Slc23a2 gene.
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